NewsRoom Articles - Page 28 of 154 - PsychedelicNewsWire (PNW)

FridayJul 14, 2023 12:16 pm

Study Shows Psilocybin Therapy Could Be Easier on the Pocketbook

A recent study by leading psychedelic academics has found that psilocybin-assisted therapy for depression could be more affordable compared to conventional treatments. Psilocybin is the main hallucinogenic agent in magic mushrooms, and as with several other psychedelics, it has been subject to increased scientific research in recent years. These scientific studies have found that psychedelics can offer relief against a plethora of mental health conditions, with psilocybin exhibiting significant potential against treatment-resistant depression. Research has found that psilocybin can also treat other mental health disorders such as obsessive-compulsive disorder and enhance positive psychological states such as optimism, happiness and satisfaction.…

ThursdayJul 13, 2023 1:38 pm

Group Psychotherapy Coupled with Psilocybin Shows Promise for Cancer Patients

A recent study has found that psilocybin-assisted group psychotherapy can help alleviate the mental woes of cancer patients with depression. While several treatments are designed to kill cancer cells and alleviate the physical symptoms caused by cancer, the mental distress associated with a cancer diagnosis and treatment is rarely addressed. Research shows that around 25% of people diagnosed with cancer suffer from depression. Cancer patients also deal with emotions such as anxiety, fear, sadness and grief, especially if they are diagnosed with particularly aggressive cancers. These psychological symptoms can cause cancer patients to become fatigued, withdrawn, lose interest in their…

WednesdayJul 12, 2023 12:30 pm

Experts Weigh in on FDA’s Draft Psychedelics Research Guidelines

For the past several years, a flurry of psychedelic-related research has found that hallucinogenic drugs have various applications in the mental health field. Researchers have found that pairing talk therapy with psychedelics is incredibly effective at alleviating conditions such as depression, anxiety and post-traumatic stress disorder. Several years after psychedelics began gaining steam as alternative mental health treatments, the U.S. Food and Drugs Administration has finally issued guidance on the management of psychedelic clinical trials. Even though initial results have been incredibly encouraging, significantly more research and clinical trials are needed before psychedelic-based treatments are developed and deployed to the…

TuesdayJul 11, 2023 2:43 pm

Bipartisan Legislators Welcome FDA Decision to Publish Psychedelics Research Guidelines

Bipartisan congressional legislators are pleased with recent actions by the U.S. Food and Drug Administration (FDA) regarding psychedelic policy and research. Only a few days after the lawmakers filed a bill requesting that the agency craft measures to guide psychedelic research in the United States, the FDA published the country’s first draft guidance on psychedelic research. Released in late June, the draft stated that psychedelics showed “initial promise” as potential therapies and outlined “unique” considerations for researchers to note during their research. The 14-page document provides America’s first-ever framework for psychedelic research and could aid in the eventual development of…

MondayJul 10, 2023 1:12 pm

Research Shows Psychedelics May Amplify Brain-Stimulation Effects

Psychedelics have enjoyed significant public interest in recent years due to their purported medical benefits. As more regions in the United States and across the world loosened psychedelic restrictions, initial research on psychedelics found that these substances could treat various mental disorders with fewer side effects. This initial research opened the flood and led to the investment of millions of dollars into psychedelic research worldwide. Continued research has revealed that several psychedelics can be effective against a multitude of mental disorders, offering sustained and long-term relief at relatively minimal doses. Scientists have been especially interested in how psychedelics affect brain…

FridayJul 07, 2023 11:21 am

WSJ Report Claims Elon Musk Uses Ketamine to Combat Depression

A recent report from The Wall Street Journal has revealed that billionaire and Twitter CEO Elon Musk uses ketamine to alleviate depression. Ketamine started as a dissociative anesthetic in the 1970s before people discovered that it also reduced depressive symptoms and suicidal thoughts. It induces a “dissociative experience,” or trip that can involve feelings of euphoria, sensory or visual distortions, temporary unusual beliefs and thoughts, and feelings of unreality for about two hours. Like some other psychedelics, ketamine has seen a surge in scientific and public interest in recent years due to its purported mental health benefits. According to the…

ThursdayJul 06, 2023 3:17 pm

Australia Starts Implementing Law That Legalized Psychedelic Therapy

Several months after traditionally conservative medical regulators in Australia approved psychedelic-assisted therapy, the country has begun implementing its landmark psychedelics law. The country’s medicine regulator approved the use of psilocybin (magic mushrooms) to alleviate treatment-resistant depression along with MDMA or ecstasy to treat post-traumatic stress disorder (PTSD). With the law taking effect July 1, 2023, Australia becomes the first country in the world to reclassify hallucinogenics as a medicine at the national level. These psychedelic reform efforts in Australia come at a time when researchers around the world are studying psychedelics with higher frequency and seeing increasingly positive results. Research…

WednesdayJul 05, 2023 2:29 pm

Jaden Smith Shares Why He Opted for Psychedelics Rather Than Other Drugs

As America has become increasingly progressive in its drug policy, psychedelics have turned from relatively obscure drugs enjoyed by a niche community to potentially game-changing mental-health treatments. Studies on hallucinogenic drugs such as psilocybin (magic mushrooms), MDMA and ayahuasca have found that these substances can safely and effectively treat various mental disorders with little side effects and at minimal doses. With the country facing an unprecedented mental-health crisis, the populace has mostly welcomed news of treatments that could potentially treat severe mental-health disorders. Public attention on psychedelics has been bolstered even more by public figures' and celebrities' accounts of their…

MondayJul 03, 2023 11:02 am

Three in Five Americans Support Psychedelic Therapy Legalization, Poll Finds

A recent poll by UC Berkeley’s Center for the Science of Psychedelics (BCSP) has revealed that a majority of Americans are in favor of legalizing psychedelic therapy. The first-ever poll of its kind, the UC Berkeley survey found that almost one-half of Americans believe that regulators should also decriminalize the recreational use of psychedelics. The Center for the Science of Psychedelics presented the survey’s findings at the Psychedelic Science 2023 conference in Denver, Colorado. Psychedelics are predicted to play a significant role in the psychiatric industry over the next couple of decades. An increasing number of studies have found that…

FridayJun 30, 2023 11:22 am

5 Main Takeaways from Denver Psychedelics Conference

The Colorado Convention Center recently hosted the latest iteration of Psychedelic Science, a massive psychedelic-themed event that attracted thousands of attendees from around the world. Psychedelic Science 2023 was the largest psychedelic conference ever held worldwide, bringing in nearly 12,000 attendees from various walks of life and a host of speakers to talk about recent events and breakthroughs in psychedelics. Here are the five main takeaways from the fourth Psychedelic Science event; Psychedelics have caught the eye of a very diverse group of people. The recent conference drew people with a diverse array of backgrounds and interests.mThe exhibition hall, for…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000